In comparison to CML progenitors, which are under the influence of BCR::ABL1, LSCs have lower expression of the oncogene and therefore rely on other BCR::ABL1-independent mechanisms for their maintenance and survival. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.